1051: A Pharmacy-Driven Rapid Bacteremia Response Program
Show notes at pharmacyjoe.com/episode1051. In this episode, I’ll discuss a pharmacy-driven rapid bacteremia response program. The post 1051: A Pharmacy-Driven…
Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning
Multiple FDA-approved drugs without lipid-lowering indications were identified to have potential lipid-lowering properties.
Blood Test Could Replace Bone Marrow Biopsies in Multiple Myeloma
SWIFT-seq revolutionizes multiple myeloma diagnosis, offering a non-invasive blood test that enhances monitoring and risk assessment for patients.
Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations
The action is supported by positive safety and efficacy findings from the phase 1a/1b first-in-human Beamion LUNG-1 trial.
Intranasal Insulin Shows Promising Brain Uptake Patterns in Alzheimer Disease
Intranasal insulin shows promise in targeting memory regions of the brain, offering new hope for Alzheimer disease treatment in older…
Large Burden of Community-Acquired Pneumonia Hospitalizations Among Older US Adults
Older adults in the United States continue to be burdened with disproportionate rates of community-acquired pneumonia hospitalizations, including due to…
Strategies to Improve Cardiovascular Health, Manage Obesity Are Evolving Rapidly
Discover effective strategies for managing obesity to enhance cardiovascular health, including innovative treatments and the vital role of pharmacists.
Debunking Misconceptions and Understanding the Stages of Type 1 Diabetes
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, explains the different stages of type 1 diabetes, teplizumab’s use, and emphasizes the pharmacist’s…